Omarigliptin
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- 951127-25-6
- Category
- Pharmaceutical Intermediates
norn pharmtech(shanghai)co.,LTD
- Verified Certificate
-
9
Product name | Omarigliptin | Certification | - |
---|---|---|---|
Category | Pharmaceutical Intermediates | Ingredients | - |
Keyword | 951127-25-6 | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | China | Stock | - |
Supply type | - | HS code | - |
Product Information
CAS:951127-25-6
Norn Pharmtech (Shanghai) co.,LTD is a high tech enterprise which engaged in the research and development of new pharmaceutical intermediates , synthesis and production .R&d center is located in the zhangjiang high-tech park, that we undertake the research and development of medical core technology and the front-end technology, the development of new products, industrial upgrading, and the adjustment of product structure. R&d center corvage the professional technology development personnel 35 people, including 9 senior experts and doctor, master of 23 people, more than 95% of the developers for young people under the age of 40. R&d center has established relatively perfect domestic system of research and development platform, that have a deep cooperation with the Chinese academy of sciences institute of organic chemistry, Institute of Material Medical and Shanghai Advanced Research Institute.
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- echo jiang
- Address
- Room 307, A building,NO.1500 Longwu road, Xuhui district.
- Product Category
- Pharmaceutical Intermediates
- Year Established
- 2012
- No. of Total Employees
- 1-50
- Company introduction
-
Norn Pharmtech (Shanghai) co.,LTD is a high tech enterprise which engaged in the research and development of new pharmaceutical intermediates , synthesis and production .R&d center is located in the zhangjiang high-tech park, that we undertake the research and development of medical core technology and the front-end technology, the development of new products, industrial upgrading, and the adjustment of product structure. R&d center corvage the professional technology development personnel 35 people, including 9 senior experts and doctor, master of 23 people, more than 95% of the developers for young people under the age of 40. R&d center has established relatively perfect domestic system of research and development platform, that have a deep cooperation with the Chinese academy of sciences institute of organic chemistry, Institute of Materia Medica and Shanghai Advanced Research Institute.
- Main Markets
-
Brazil
Germany
India
Israel
Italy
Japan
North Korea
Russia
South Korea
Ukraine
- Main Product
Related Products
Hydrocoralliaire- Klonopin- Lexapro
Cas 160149-03-1
3-amino-2-methylamino-5-(trifluoromethyl)pyridine
beta-cyclodextrin
Betamethasone 17-valerate